Literature DB >> 21125343

B-lymphocyte effector functions in health and disease.

David J DiLillo1, Mayuka Horikawa, Thomas F Tedder.   

Abstract

B-lymphocytes have traditionally been thought to contribute to immunity and autoimmune disease through terminal differentiation into plasma cells that secrete antibody. However, studies in mice and recent clinical studies have demonstrated that genetically altered B-cell function and B-cell-targeted therapies can significantly affect autoimmune diseases that were predominantly thought to be T-cell-mediated. B-cell depletion in mouse models of disease has also led to the identification of alternative B-cell effector functions that regulate normal immune responses and autoimmune disease. This review highlights multiple B-cell effector mechanisms, including the promotion of cellular immunity, the negative regulation of immune responses, and the production of pathogenic antibodies.

Entities:  

Mesh:

Year:  2011        PMID: 21125343     DOI: 10.1007/s12026-010-8189-3

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  60 in total

1.  B cell-dependent TCR diversification.

Authors:  Cristina João; Brenda M Ogle; Carlota Gay-Rabinstein; Jeffrey L Platt; Marilia Cascalho
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

2.  Identifying regulatory B cells (B10 cells) that produce IL-10 in mice.

Authors:  Takashi Matsushita; Thomas F Tedder
Journal:  Methods Mol Biol       Date:  2011

Review 3.  A case for regulatory B cells.

Authors:  Atsushi Mizoguchi; Atul K Bhan
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

4.  Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells.

Authors:  Alison Crawford; Megan Macleod; Ton Schumacher; Louise Corlett; David Gray
Journal:  J Immunol       Date:  2006-03-15       Impact factor: 5.422

Review 5.  B lymphocytes: how they develop and function.

Authors:  Tucker W LeBien; Thomas F Tedder
Journal:  Blood       Date:  2008-09-01       Impact factor: 22.113

Review 6.  Cytokine-producing B lymphocytes-key regulators of immunity.

Authors:  Frances E Lund
Journal:  Curr Opin Immunol       Date:  2008-04-15       Impact factor: 7.486

7.  Lifetime of plasma cells in the bone marrow.

Authors:  R A Manz; A Thiel; A Radbruch
Journal:  Nature       Date:  1997-07-10       Impact factor: 49.962

8.  Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis.

Authors:  Takashi Matsushita; Mayuka Horikawa; Yohei Iwata; Thomas F Tedder
Journal:  J Immunol       Date:  2010-07-12       Impact factor: 5.422

9.  Role of B cells as antigen-presenting cells in vivo revisited: antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations.

Authors:  A Rivera; C C Chen; N Ron; J P Dougherty; Y Ron
Journal:  Int Immunol       Date:  2001-12       Impact factor: 4.823

Review 10.  The 'short' history of regulatory B cells.

Authors:  Claudia Mauri; Michael R Ehrenstein
Journal:  Trends Immunol       Date:  2007-12-03       Impact factor: 16.687

View more
  21 in total

1.  L-selectin deficiency decreases aortic B1a and Breg subsets and promotes atherosclerosis.

Authors:  Breanne N Gjurich; Parésa L Taghavie-Moghadam; Klaus Ley; Elena V Galkina
Journal:  Thromb Haemost       Date:  2014-07-03       Impact factor: 5.249

2.  High-affinity σ1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis.

Authors:  B Oxombre; C Lee-Chang; A Duhamel; M Toussaint; M Giroux; M Donnier-Maréchal; P Carato; D Lefranc; H Zéphir; L Prin; P Melnyk; P Vermersch
Journal:  Br J Pharmacol       Date:  2015-02-10       Impact factor: 8.739

3.  Chronic airway inflammation provides a unique environment for B cell activation and antibody production.

Authors:  S Feldman; R Kasjanski; J Poposki; D Hernandez; J N Chen; J E Norton; L Suh; R G Carter; W W Stevens; A T Peters; R C Kern; D B Conley; B K Tan; S Shintani-Smith; K C Welch; L C Grammer; K E Harris; A Kato; R P Schleimer; K E Hulse
Journal:  Clin Exp Allergy       Date:  2017-01-26       Impact factor: 5.018

4.  Regulatory B cell (B10 Cell) expansion during Listeria infection governs innate and cellular immune responses in mice.

Authors:  Mayuka Horikawa; Eric T Weimer; David J DiLillo; Guglielmo M Venturi; Rosanne Spolski; Warren J Leonard; Mark T Heise; Thomas F Tedder
Journal:  J Immunol       Date:  2012-12-28       Impact factor: 5.422

Review 5.  B10 cell regulation of health and disease.

Authors:  Kathleen M Candando; Jacquelyn M Lykken; Thomas F Tedder
Journal:  Immunol Rev       Date:  2014-05       Impact factor: 12.988

Review 6.  New insights on innate B-cell immunity in transplantation.

Authors:  Emmanuel Zorn
Journal:  Xenotransplantation       Date:  2018-05       Impact factor: 3.907

Review 7.  Regulatory B10 cell development and function.

Authors:  Jacquelyn M Lykken; Kathleen M Candando; Thomas F Tedder
Journal:  Int Immunol       Date:  2015-08-06       Impact factor: 4.823

Review 8.  To B or not to B cells-mediate a healthy start to life.

Authors:  T G Nguyen; C M Ward; J M Morris
Journal:  Clin Exp Immunol       Date:  2013-02       Impact factor: 4.330

9.  Absence of immune responses with xenogeneic collagen and elastin.

Authors:  Alexandra Bayrak; Pauline Prüger; Ulrich A Stock; Martina Seifert
Journal:  Tissue Eng Part A       Date:  2013-04-15       Impact factor: 3.845

10.  Relapsing-remitting central nervous system autoimmunity mediated by GFAP-specific CD8 T cells.

Authors:  Katsuhiro Sasaki; Angela Bean; Shivanee Shah; Elizabeth Schutten; Priya G Huseby; Bjorn Peters; Zu T Shen; Vijay Vanguri; Denny Liggitt; Eric S Huseby
Journal:  J Immunol       Date:  2014-03-03       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.